A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers

Andreas Nikolis,1 Doria Grimard,2 Yves Pesant,3 Giovanni Scapagnini,4 Denis Vézina5 1Division of Plastic Surgery, Victoria Park Research Centre, Montreal, 2Q&T Research Chicoutimi, Chicoutimi, 3St-Jerome Medical Research Inc., St-Jerome, Quebec, Canada; 4Department of Medicine and...

Full description

Bibliographic Details
Main Authors: Nikolis A, Grimard D, Pesant Y, Scapagnini G, Vézina D
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:Chronic Wound Care Management and Research
Subjects:
Online Access:https://www.dovepress.com/a-prospective-case-series-evaluating-the-safety-and-efficacy-of-the-kl-peer-reviewed-article-CWCMR
id doaj-b91f9707f6774c66bd3e01d186581918
record_format Article
spelling doaj-b91f9707f6774c66bd3e01d1865819182020-11-24T23:05:53ZengDove Medical PressChronic Wound Care Management and Research2324-481X2016-09-01Volume 310111128924A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcersNikolis AGrimard DPesant YScapagnini GVézina DAndreas Nikolis,1 Doria Grimard,2 Yves Pesant,3 Giovanni Scapagnini,4 Denis Vézina5 1Division of Plastic Surgery, Victoria Park Research Centre, Montreal, 2Q&T Research Chicoutimi, Chicoutimi, 3St-Jerome Medical Research Inc., St-Jerome, Quebec, Canada; 4Department of Medicine and Health Sciences, School of Medicine, University of Molise, Campobasso, Italy; 5Klox Technologies, Laval, Quebec, Canada Purpose: To investigate the safety and efficacy of the BioPhotonic System developed by Klox Technologies in a case series of ten patients with venous leg ulcers.Patients and methods: Ten patients with chronic venous leg ulcers, having failed on at least one previous therapy, were enrolled into this case series.Results: Nine patients were evaluable for efficacy. A response (defined as decrease in wound surface area) was observed in seven patients (77.8%). Of these, four patients (44.4%) achieved wound closure on average 4 months (127.5 days) following the beginning of the treatment. Two patients did not respond to the investigational treatment. Quality of life improved over time throughout the study. Compliance was excellent, with 93.2% of visits completed as per protocol. Safety was unremarkable, with only four treatment-emergent-related adverse events, for which no specific intervention was required.Conclusion: The BioPhotonic System was shown to be safe and extremely well tolerated. It also demonstrated potential in terms of wound closure, wound surface area decrease, and wound bed preparation. Keywords: biophotonics, light, photobiomodulation, venous leg ulcershttps://www.dovepress.com/a-prospective-case-series-evaluating-the-safety-and-efficacy-of-the-kl-peer-reviewed-article-CWCMRBiophotonicsLightChromophoreChronic woundsVenous leg ulcers
collection DOAJ
language English
format Article
sources DOAJ
author Nikolis A
Grimard D
Pesant Y
Scapagnini G
Vézina D
spellingShingle Nikolis A
Grimard D
Pesant Y
Scapagnini G
Vézina D
A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers
Chronic Wound Care Management and Research
Biophotonics
Light
Chromophore
Chronic wounds
Venous leg ulcers
author_facet Nikolis A
Grimard D
Pesant Y
Scapagnini G
Vézina D
author_sort Nikolis A
title A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers
title_short A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers
title_full A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers
title_fullStr A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers
title_full_unstemmed A prospective case series evaluating the safety and efficacy of the Klox BioPhotonic System in venous leg ulcers
title_sort prospective case series evaluating the safety and efficacy of the klox biophotonic system in venous leg ulcers
publisher Dove Medical Press
series Chronic Wound Care Management and Research
issn 2324-481X
publishDate 2016-09-01
description Andreas Nikolis,1 Doria Grimard,2 Yves Pesant,3 Giovanni Scapagnini,4 Denis Vézina5 1Division of Plastic Surgery, Victoria Park Research Centre, Montreal, 2Q&T Research Chicoutimi, Chicoutimi, 3St-Jerome Medical Research Inc., St-Jerome, Quebec, Canada; 4Department of Medicine and Health Sciences, School of Medicine, University of Molise, Campobasso, Italy; 5Klox Technologies, Laval, Quebec, Canada Purpose: To investigate the safety and efficacy of the BioPhotonic System developed by Klox Technologies in a case series of ten patients with venous leg ulcers.Patients and methods: Ten patients with chronic venous leg ulcers, having failed on at least one previous therapy, were enrolled into this case series.Results: Nine patients were evaluable for efficacy. A response (defined as decrease in wound surface area) was observed in seven patients (77.8%). Of these, four patients (44.4%) achieved wound closure on average 4 months (127.5 days) following the beginning of the treatment. Two patients did not respond to the investigational treatment. Quality of life improved over time throughout the study. Compliance was excellent, with 93.2% of visits completed as per protocol. Safety was unremarkable, with only four treatment-emergent-related adverse events, for which no specific intervention was required.Conclusion: The BioPhotonic System was shown to be safe and extremely well tolerated. It also demonstrated potential in terms of wound closure, wound surface area decrease, and wound bed preparation. Keywords: biophotonics, light, photobiomodulation, venous leg ulcers
topic Biophotonics
Light
Chromophore
Chronic wounds
Venous leg ulcers
url https://www.dovepress.com/a-prospective-case-series-evaluating-the-safety-and-efficacy-of-the-kl-peer-reviewed-article-CWCMR
work_keys_str_mv AT nikolisa aprospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT grimardd aprospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT pesanty aprospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT scapagninig aprospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT veacutezinad aprospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT nikolisa prospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT grimardd prospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT pesanty prospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT scapagninig prospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
AT veacutezinad prospectivecaseseriesevaluatingthesafetyandefficacyofthekloxbiophotonicsysteminvenouslegulcers
_version_ 1725625173922545664